This announcement is a separate document:
毕得医药：上海毕得医药科技股份有限公司监事会关于公司2024年限制性股票激励计划首次授予激励对象名单的审核意见及公示情况说明
Bide Pharmaceutical: Explanation of the review opinions and disclosure of the supervisory board of Shanghai Bide Pharmaceutical Technology Co., Ltd. on the list of incentive recipients granted for the first time in the company\'s 2024 restricted stock incentive plan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated